FIELD: chemistry.
SUBSTANCE: invention relates to chemical-pharmaceutical industry and represents a method of producing a pharmaceutical composition in the form of capsules, consisting in the fact that is preliminarily sieved substance fingolimod hydrochloride, microcrystalline cellulose, carboxymethyl sodium and calcium stearate or magnesium stearate, mixed in weight ratio of 1:(210-215):(5-7):(1.5-2.5), respectively, to a homogeneous state and dosed mixture in the capsule.
EFFECT: invention provides higher accuracy of metering in production of capsules, stable during storage of the product.
3 cl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| SOLID ORAL PHARMACEUTICAL COMPOSITION OF S1P AGONIST OR ITS PHARMACEUTICALLY ACCEPTABLE SALT, METHOD FOR ITS PRODUCTION AND METHODS FOR TREATMENT AND REDUCTION OF FREQUENCY OF CLINICAL EXACERBATIONS OF MULTIPLE SCLEROSIS | 2015 |
|
RU2639424C2 |
| PHARMACEUTICAL COMPOSITION OF SIP RECEPTOR AGONIST FOR TREATING DEMYELINIATING DISEASES | 2012 |
|
RU2506949C1 |
| METHOD FOR PREPARING PHARMACEUTICAL COMPOSITION | 2010 |
|
RU2475236C2 |
| ORGANIC COMPOUNDS | 2004 |
|
RU2358716C2 |
| ORAL PHARMACEUTICAL COMPOSITION | 2010 |
|
RU2475237C2 |
| PHARMACEUTICAL COMPOSITIONS CONTAINING S1P RECEPTOR MODULATOR | 2007 |
|
RU2487703C2 |
| PHARMACEUTICAL COMPOSITION OF S1P RECEPTOR AGONIST FOR TREATING DEMYELINIATING DISEASES | 2013 |
|
RU2530626C1 |
| PHARMACEUTICAL COMPOSITION EXHIBITING IMPROVED FLOWABILITY, DRUG PREPARATION, METHOD FOR PREPARING AND USING | 2012 |
|
RU2496486C1 |
| CRYSTALLINE FORMS OF FINGOLIMOD HYDROCHLORIDE | 2009 |
|
RU2549899C2 |
| PAEDIATRIC COMPOSITIONS FOR TREATING MULTIPLE SCLEROSIS | 2009 |
|
RU2562571C2 |
